Glibenclamide
Sold as Diacare, Daonil, Glycomin, Glibenclamide oethmaan, Melix, Bio glibenclamide
5-Chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide
Drag to rotate. Structure from PubChem CID 3488.
Background
Registration
- Applicants
- 6
- Registrations
- 8
- Schedule source
- Consolidated Schedules 06 July 2026
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Unimed Healthcare (Pty) Ltd | Diacare | Not stated | 320407 | S3 | None |
| Sanofi-aventis South Africa (Pty) LtdCancelled | Daonil | Not stated | G3036 | S3 | None |
| Adcock ingram limited | Glycomin | 3,5 | Q0024, W0359 | S3 | None |
| Oethmaan Biosims (Pty) Ltd | Glibenclamide oethmaan | 5 | T0150 | S3 | None |
| Pharmacare limited û woodmead1 of 2 cancelled | Melix, Glycomin | 2,5 | T0174, Z0066 | S3 | None |
| Biotech Laboratories (Pty) Ltd | Bio glibenclamide | 5 | V0345 | S3 | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Diacare EACH TABLET CONTAINS GLIBENCLAMIDE 5,0 mg | Not listed | 32040732/21.2/0407 | Registered | S3 | None |
| Daonil EACH TABLET CONTAINS GLIBENCLAMIDE A 5 mg | Not listed | G3036 | Cancelled | S3 | None |
| Glycomin EACH TABLET CONTAINS GLIBENCLAMIDE 5 MG | Not listed | Q0024Q/21.2/24 | Registered | S3 | None |
| Glibenclamide 5 oethmaan EACH TABLET CONTAINS GLIBENCLAMIDE 5 mg | 5 | T0150T/21.2/150 | Registered | S3 | None |
| Melix EACH TABLET CONTAINS GLIBENCLAMIDE 5 mg | Not listed | T0174T/21.2/174 | Cancelled | S3 | None |
| Bio glibenclamide 5 EACH TABLET CONTAINS GLIBENCLAMIDE 5 mg | 5 | V0345V/21.2/345 | Registered | S3 | None |
| Glycomin - 3,5 EACH TABLET CONTAINS GLIBENCLAMIDE 3,5 mg | - 3,5 | W0359W/21.2/359 | Registered | S3 | None |
| Glycomin - 2,5 EACH TABLET CONTAINS GLIBENCLAMIDE 2,5 mg | - 2,5 | Z0066Z/21.2/66 | Registered | S3 | None |
Regulatory status
Where S3 sits on the scale
Needs a doctor's prescription, dispensed by a pharmacist.
Schedule 3 medicines can only be sold on a prescription from an authorised prescriber, such as a doctor or dentist. A pharmacist dispenses the medicine once they have the written prescription, or a verbal instruction from a prescriber they know. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S3, matched to the Consolidated Schedules by ingredient, confidence high.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Glibenclamide
S3: Glibenclamide
Consolidated Schedules 06 July 2026, line 3671
Pharmacological class: Oral hypoglycaemics. (class 21.2)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.